Coltene Holding AG's EBIT per Share for the
six
months ended in Dec. 2025 was CHF1.92.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was CHF3.18.
During the past 12 months, the average EBIT per Share Growth Rate of Coltene Holding AG was -21.70% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -15.60% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -11.20% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -3.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Coltene Holding AG's EBIT per Share or its related term are showing as below:
XSWX:CLTN'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -18.6 Med: -0.25 Max: 21.4
Current: -15.6
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Coltene Holding AG was 21.40% per year. The lowest was -18.60% per year. And the median was -0.25% per year.
XSWX:CLTN's 3-Year EBIT Growth Rate is ranked worse than 80.29% of 690
companies
in the Medical Devices & Instruments industry
Industry Median: 9.5
vs XSWX:CLTN: -15.60
Coltene Holding AG (XSWX:CLTN) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Coltene Holding AG EBIT per Share Related Terms
Coltene Holding AG EBIT per Share Historical Data
* Premium members only.
The historical data trend for Coltene Holding AG's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF3.18
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Coltene Holding AG (XSWX:CLTN) has a EBIT per Share of CHF3.18 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Coltene Holding AG and its competitors. According to the industry distribution chart, Coltene Holding AG ranks #554 out of 690 companies in the Medical Devices & Instruments industry, placing it in the top 80.3%.
Is Coltene Holding AG's EBIT per Share too high?
Coltene Holding AG's current EBIT per Share is CHF3.18. Based on the distribution chart, Coltene Holding AG ranks #554 out of 690 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Coltene Holding AG has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Coltene Holding AG's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Coltene Holding AG ranks #554 out of 690 companies for EBIT per Share. This places Coltene Holding AG in the lower half of its industry. The industry median EBIT per Share is 9.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.50, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Coltene Holding AG and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coltene Holding AG's current EBIT per Share is CHF3.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coltene Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Coltene Holding AG (XSWX:CLTN) is currently considered Fairly Valued. The stock's GF Value™ is CHF55.14, compared to a current price of CHF50.10 — trading 9.1% below its estimated fair value. The current EBIT per Share is CHF3.18. Coltene Holding AG's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Coltene Holding AG (XSWX:CLTN), the current EBIT per Share is CHF3.18 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Coltene Holding AG (XSWX:CLTN) Overvalued in 2026?
Based on GuruFocus' analysis, Coltene Holding AG stock appears to be undervalued.
The current stock price of CHF50.10 is trading 9.1% below its estimated GF Value™ of CHF55.14.
GuruFocus considers Coltene Holding AG to be Fairly Valued.
Key valuation signals for XSWX:CLTN:
EBIT per Share: CHF3.18
GF Value™: CHF55.14 vs. price of CHF50.10 (9.1% below fair value)
No single metric tells the full story. See the XSWX:CLTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Coltene Holding AG is a manufacturer and distributor of consumables and small devices for dental practices, dental service organisations (DSOs), dental clinics and laboratories, as well as for non-dental niches (e.g., clinics for ophthalmology or podiatry). The Group develops, manufactures, and sells mainly via distribution channels a broad and comprehensive range of disposables, tools, and equipment for dentists and dental laboratories. Geographically, it operates in EMEA, North America, Latin America, and Asia/Oceania, with maximum from North America.
69GF Score
Get the complete analysis for XSWX:CLTN
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:CLTN has been successfully added to your 
